UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059946
Receipt number R000068565
Scientific Title Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination
Date of disclosure of the study information 2025/12/02
Last modified on 2025/12/02 14:52:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination

Acronym

Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination

Scientific Title

Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination

Scientific Title:Acronym

Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination Clinical Characteristics of Gastric Cancer Occurring After Bacteria Elimination

Region

Japan


Condition

Condition

Gastric Cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to clarify the clinical characteristics of gastric cancer occurring after Helicobacter pylori eradication and to evaluate its association with background diseases and patient profiles at the time of eradication. Specifically, we will conduct a detailed analysis of endoscopic findings before and after eradication, the degree of atrophic gastritis, the incidence rate of gastric cancer after eradication, and the characteristics of the resulting gastric cancers, including location, morphology, size, depth of invasion, and histological type. This aims to understand the characteristics of gastric cancers developing after eradication and to gain insights that will contribute to improving future treatment and preventive strategies.

Basic objectives2

Others

Basic objectives -Others

Characterizing gastric cancer occurring after eradication

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of Background Diseases and Patient Profiles at the Time of Eradication with Characteristics of Gastric Cancer Occurring After Helicobacter pylori Eradication

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients aged 18 years or older at the time of Helicobacter pylori eradication therapy who underwent treatment at Keio University Hospital between January 2012 and August 2024 and were subsequently newly diagnosed with gastric cancer by October 2024.

Key exclusion criteria

1 Individuals who refused to allow their clinical data to be used. 2 Patients who had concomitant gastric cancer planned for treatment during Helicobacter pylori eradication therapy. 3 Patients who received Helicobacter pylori eradication therapy at another hospital.

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Mori

Organization

Keio University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

1608582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

0333531211

Email

mori-d@keio.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Mori

Organization

Keio University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

1608582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

0333531211

Homepage URL


Email

mori-d@keio.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

35 Shinanomachi, SHinjuku-ku, Tokyo

Tel

0333531211

Email

med-rinri-ft_pt@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 02 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi

Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

42

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 12 Month 02 Day

Date of IRB

2024 Year 12 Month 23 Day

Anticipated trial start date

2024 Year 12 Month 24 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective study


Management information

Registered date

2025 Year 12 Month 02 Day

Last modified on

2025 Year 12 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068565